AI assistant
IDEXX LABORATORIES INC /DE — Director's Dealing 2021
Feb 17, 2021
30016_dirs_2021-02-17_435beb35-5bab-448a-a53e-7fc65ccb435c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2021-02-14
Reporting Person: TWIGGE GIOVANI (Senior Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-02-14 | Common Stock | M | 405 | — | Acquired | 13340 | Direct |
| 2021-02-14 | Common Stock | M | 212 | — | Acquired | 13552 | Direct |
| 2021-02-14 | Common Stock | M | 168 | — | Acquired | 13720 | Direct |
| 2021-02-14 | Common Stock | M | 157 | — | Acquired | 13877 | Direct |
| 2021-02-14 | Common Stock | M | 184 | — | Acquired | 14061 | Direct |
| 2021-02-14 | Common Stock | F | 338 | $544.08 | Disposed | 13723 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-02-14 | Non-Qualified Stock Option (right-to-buy) | $544.08 | A | 4236 | Acquired | 2031-02-13 | Common Stock (4236) | Direct |
| 2021-02-14 | Incentive Stock Option (right-to-buy) | $544.08 | A | 183 | Acquired | 2031-02-13 | Common Stock (183) | Direct |
| 2021-02-14 | Restricted Stock Unit | $ | A | 459 | Acquired | Common Stock (459) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 405 | Disposed | Common Stock (405) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 212 | Disposed | Common Stock (212) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 168 | Disposed | Common Stock (168) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 157 | Disposed | Common Stock (157) | Direct | |
| 2021-02-14 | Restricted Stock Unit | $ | M | 184 | Disposed | Common Stock (184) | Direct |
Footnotes
F1: Includes 13 shares purchased under the Issuer's Employee Stock Purchase Plan on December 31, 2020.
F2: Closing price of Issuer common stock on the NASDAQ Global Select Market on February 12, 2021.
F3: Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2022.
F4: Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on the fourth anniversary of the date of grant.
F5: Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2022.
F6: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vested in five annual installments, beginning February 14, 2017.
F7: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2018.
F8: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2019.
F9: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in five annual installments, beginning February 14, 2020.
F10: Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2021.
F11: Not applicable.